Available in English and Spanish, this e-newsletter separates fact from fiction on over 40 heart topics.
Texas Heart Institute (THI) conducts research through clinical trials as part of our mission to improve heart health. The trials conducted at THI are designed to test the safety and effectiveness of innovative new treatments and medications for patients.
Grand Rounds provides a weekly opportunity to learn from leading medical and surgical experts, sharing the latest advancements and innovation in the diagnosis, treatment, and prevention of cardiovascular disease.
Our progress would not be possible without our donor community. Help support our mission by giving today.
Houston, TX (September 23, 2016) – Texas Heart Institute President James T. Willerson, MD, was honored at last night’s Texans for Cures “Hearts and...
Houston, TX (August 18, 2016) – Texas Heart Institute has been resurveyed by the Accreditation Council for Continuing Medical Education...
Stem Cell Tourism Near and Far: Achieving a Compromise for the Patient Houston, TX (September 22, 2016) – Patient advocacy groups...
Researchers in Cardiomyocyte Renewal Lab pave the way for new discovery Houston, TX (June 7, 2016) – The Texas Heart Institute...
Houston, TX (June 1, 2016) – Stem cells have been shown to produce a variety of substances that promote tissue repair...
EVAR and TVAR at “101 years young” Houston, TX (May 31, 2016) – Samuel Henderson lives in Louisiana, and enjoys spending...
Institute Positioned for Purposeful Discovery and Global Influence Houston, TX (May 25, 2016) – The Texas Heart Institute announced the...
Houston, Texas (January 19, 2016) – A new clinical study published in the January issue of Gene Therapy reports the promising results...
Cardiovascular surgeon and Cleveland Clinic president honored by Texas Heart Institute for scientific achievements, contributions to healthcare Houston, Texas (January...
